CDMO News news

Chemical industry CDMO (contract development and manufacturing organization) news

6 December 2024
WuXi Biologics Hits Key Milestones at Ireland Site with 16,000L PPQ Success and HPRA GMP Approvals
The Dundalk site completed two successful PPQ runs and received GMP approval, enhancing its role in global biomanufacturing with innovative, sustainable processes and strong regulatory compliance.
6 November 2024
Tosoh Bioscience Expands European HQ in Germany
The expanded HQ features advanced labs and training areas for chromatography, enhancing customer collaboration and innovation in biomolecule and polymer analysis.
7 October 2024
PCI Pharma invests $365M in EU and US facilities for advanced drug delivery and device products
Investments enhance drug-device assembly, packaging, and storage in the US and EU, focusing on injectables and biologics, with new facilities in Illinois and Ireland.
21 September 2024
Lilly Invests $1.8 Billion in Irish Manufacturing Expansion
The $1.8B investment will boost production of Alzheimer's, diabetes, and obesity treatments, create 150 jobs, and enhance sustainability with advanced technologies and a solar farm.
28 June 2024
EuroAPI FOCUS-27 Plan: Job Cuts and Facility Divestments
The FOCUS-27 plan aims to boost competitiveness with €110-120M restructuring costs, €350-400M CAPEX, and €75-80M annual EBITDA by 2027, focusing on high-value APIs and strategic sites.
23 June 2024
WACKER and CordenPharma Achieve Pandemic Readiness in June 2024
The consortium will produce 80 million mRNA vaccine doses annually if needed, following a successful expansion and qualification phase, ensuring pandemic readiness for at least five years.

CDMO projects

A map displaying all CDMO projects in Europe

A map of CDMO projects that are planned or currently being executed.

Use chemXplore Analytics to power your research into CDMO.

Learn more

Scheduled completion

This chart shows how many CDMO projects in the European chemical industry are expected to be completed in the upcoming years.

Learn more

The right choices in the European chemical industry

Save time with chemXplore Analytics

Next →

New construction vs expansion

Owners & Investors

Top 5 companies involved as owner and/or investor in current and planned CDMO projects:

Merck, Sandoz, Lonza, WACKER, Novo Nordisk, WCGC, WuXi, ACG, Arxada, and PCI Pharma Services.